本页面由Tiger Trade Technology Pte. Ltd.提供服务

Maravai LifeSciences Holdings, Inc.

7.06
-0.3800-5.11%
盘前:7.100.0400+0.57%05:09 EDT
成交量:125.32万
成交额:889.04万
市值:18.33亿
市盈率:-13.32
高:7.38
开:7.38
低:6.95
收:7.44
52周最高:9.42
52周最低:2.55
股本:2.60亿
流通股本:1.03亿
量比:0.38
换手率:1.22%
股息:- -
股息率:- -
每股收益(TTM):-0.5299
每股收益(LYR):-0.9059
净资产收益率:-33.05%
总资产收益率:-5.71%
市净率:8.96
市盈率(LYR):-7.79

数据加载中...

2026/09/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/07

重要事件披露

Form 8-K - Current report
2026/06/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/23

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/03

重要事件披露

Form 8-K - Current report
2026/05/29

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/08

重要事件披露

Form 8-K - Current report
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2025/12/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]